EP Edge Journal Watch
Niraj Sharma MD FACC FHRS
0
EP Edge Journal Watch is a bi-weekly podcast hosted by Dr. Niraj Sharma that distills high-impact cardiovascular and electrophysiology research into clear, clinically meaningful insights. Each episode goes beyond headlines and abstracts to uncover what new studies mean for patient care and decision-making. The podcast focuses on evidence-based practice, precision electrophysiology, and a forward-thinking approach to interpreting data in real-world clinical settings. It is designed for electrophysiologists, cardiologists, researchers, trainees, and allied health professionals who want to stay ahead of the curve.
Episodes
-
EP Edge® Journal Watch 45, November 2026: Pulsed Field Ablation for AF, Pacing, Cannabis and Anticoagulation 16.11.2026 27mDoes a shorter atrial fibrillation ablation give patients the same chance of staying in sinus rhythm a year later? In Issue 45 of EP Edge® Journal Watch, Dr. Niraj Sharma reviews 16 electrophysiology publications, from choosing an ablation catheter to deciding whether a patient with AF and a remote coronary stent still needs aspirin.TWOSOME | Single-shot vs point-by-point pulsed field ablationIn 100 patients undergoing their first pulmonary vein isolation for paroxysmal AF, median procedure time was 43 minutes with single-shot PFA and 118 minutes with focal PFA. At 12 months, estimated freedom... -
EP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and Exercise 09.11.2026 27mEP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and ExerciseWhat should count as successful atrial fibrillation ablation? Can shorter follow-up reliably assess treatment effectiveness? How might conduction system pacing, atrial physiology, and exercise intensity influence the way we evaluate and manage arrhythmia risk?In Issue 44 of EP Edge® Journal Watch, Dr. Sharma examines five featured publications in depth, explaining their rationale, methods, findings, statistical interpretation, limitations, and practical implications. The episode also provides... -
EP Edge® Journal Watch: Issue 43 November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis 02.11.2026 27mEP Edge® Journal Watch 43 | November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and EndocarditisHow should we judge new ventricular ablation technologies, reassess survivors of apparently idiopathic ventricular fibrillation, and weigh the long-term consequences of pacing and infection-management decisions?In Issue 43 of EP Edge Journal Watch, Dr. Sharma examines ventricular arrhythmias, cardiac resynchronization, implanted-device safety, and infective endocarditis. Four featured discussions cover CLEAR-VT with its companion device analysis, long-term outcomes after idiopathic ventricu... -
EP Edge® Journal Watch Issue 42, October 2026, with the Heart Rhythm Society: PIFPAF-PFA, His-Alternative II, and AF Density in Stroke Risk 26.10.2026 33mDoes more extensive atrial fibrillation ablation improve outcomes? Can conduction system pacing replace conventional biventricular cardiac resynchronization therapy? And does the temporal distribution of atrial fibrillation predict ischemic stroke better than cumulative AF burden alone?In Issue 42 of EP Edge® Journal Watch, October 2026, presented in collaboration with the Heart Rhythm Society (HRS), Drs. Niraj Sharma and Michael Llyod examines three important electrophysiology studies addressing atrial fibrillation ablation, physiological pacing, heart failure, and stroke risk stratification.... -
EP Edge® Journal Watch: Issue 41 October 2026: AF Ablation, PFA Coronary Safety, Smartwatches and LAA Closure 19.10.2026 27mEP Edge® Journal Watch 41 | October 2026: AF Ablation, PFA Coronary Safety, Smartwatches and LAA ClosureWhen does a more extensive ablation strategy improve outcomes, how should we assess coronary safety after pulsed field ablation, and can wearable rhythm monitoring or left atrial appendage closure change clinical decisions?In Issue 41 of EP Edge Journal Watch, Dr. Sharma examines atrial fibrillation treatment, procedural safety, rhythm monitoring, and stroke prevention. Four featured discussions explore low-voltage area ablation, the IMPACT-CTI study, smartwatch assessment of AF burden, and... -
EP Edge® Journal Watch 40, October 2026: AF Ablation, Anticoagulation, Stroke Risk, GLORIA-AF, Stellate Ganglion Block, and ICD Outcomes 12.10.2026 37mEP Edge® Journal Watch | Issue 40 | October 2026Beyond AF Burden: Stroke Risk, Rhythm Progression, Atrial Pacing, and Sudden Death PreventionShould oral anticoagulation continue after successful atrial fibrillation ablation? Does AF density provide better stroke-risk information than conventional burden measurements? Can the GLORIA-AF score improve thromboembolic risk prediction? And could autonomic modulation or advances in pacing and defibrillator therapy change electrophysiology practice?In Issue 40 of EP Edge® Journal Watch, Dr. Sharma examines eleven research papers, with detailed analysi... -
EP Edge® Journal Watch 39 | October 2026: PIFPAF-PFA, Ablation Durability and Left Bundle Area ICD Leads 05.10.2026 25mShould we add posterior wall isolation during pulsed field ablation for persistent atrial fibrillation? How durable are pulmonary vein isolation and additional atrial lines? Can a defibrillation lead placed in the left bundle branch area provide reliable early performance while simplifying device therapy?Join Dr. Sharma for EP Edge® Journal Watch Issue 39, October 2026. We examine four papers in depth: PIFPAF-PFA, pulmonary vein isolation durability across pulsed field systems, invasive remapping of atrial lesion sets with a dual-energy lattice-tip catheter, and the LEADR LBBAP defibrillation... -
EP Edge® Journal Watch Issue 38 September 2026 with Heart Rhythm Society at HRX: AI ECG Interpretation, Wearable-Detected Ventricular Tachycardia, and LBBAP vs Deep Septal Pacing 28.09.2026 15mIn this special EP Edge® Journal Watch Issue 38, recorded at HRX, with the Heart Rhythm Society Live 2026 in Atlanta, Dr. Niraj Sharma is joined by Dr. Michael Lloyd, Professor of Medicine at Emory University, for a focused discussion of three provocative studies with direct implications for contemporary cardiac electrophysiology.First, they examine the emerging role of large language models and artificial intelligence in ECG interpretation. How accurately can off-the-shelf, zero-shot LLMs interpret electrocardiograms, and are currently available general-purpose AI models ready to participate... -
EP Edge® Journal Watch 37: LAAO vs DOACs, PFA Stroke Risk, Wearable AF Monitoring, PVC Localization, and SGLT2 Sudden Death 21.09.2026 33mIn EP Edge® Journal Watch Issue 37, September 2026, Dr. Sharma reviews 13 important studies in cardiac electrophysiology, with a focus on what the data actually mean for clinical practice. This episode goes beyond abstracts and headline results to examine why each study was performed, the clinical question investigators were trying to answer, the methodology used, the statistics behind the major findings, important limitations, and what the results may mean for electrophysiologists going forward.This episode begins with a major theme in contemporary atrial fibrillation care: left atrial append... -
EP Edge® Journal Watch 36: ESC 2026, AF Ablation and Sham Trials | PVI-SHAM-AF, PFA-SHAM, SHAM-PVI, FlexPulse, NEXAF, IDEAL-AF, ENRICH-AF 14.09.2026 31mWhat defines successful atrial fibrillation ablation: fewer recurrences, lower AF burden, better quality of life, or all three? In this ESC Congress 2026 special issue of EP Edge Journal Watch, Dr. Sharma examines evidence from Munich, Germany, August 28–31, 2026, alongside previously covered sham-controlled trials to explore what meaningful patient benefit should look like.PVI-SHAM-AF leads the discussion. Rolf Wachter and colleagues found lower sampled atrial fibrillation burden after catheter ablation, but no demonstrated superiority over sham on the primary Atrial Fibrillation Effect on Qu... -
EP Edge® Journal Watch Issue 35: ESC 2026 Munich Special Edition | SINGLE-AF, CMR GUIDE, New HF Guidelines & Fifth Universal Definition of MI 07.09.2026 21mIn this special edition of EP Edge® Journal Watch, Dr. Sharma reviews the major breaking cardiovascular and electrophysiology science presented at the European Society of Cardiology Congress 2026 in Munich.The episode begins with two important electrophysiology trials that challenge familiar clinical thresholds.First is SINGLE-AF, led by Daehoon Kim and colleagues and published in the New England Journal of Medicine in August 2026. The trial provides the first randomized evidence evaluating direct oral anticoagulation versus no anticoagulation in patients with atrial fibrillation at intermedia... -
EP Edge® × HRS: Rethinking the Defaults: AFib Ablation vs Antiarrhythmics, Flecainide Beyond CAST, and Physiologic Pacing 31.08.2026 37mIn this EP Edge and Heart Rhythm Society collaborative podcast, Dr. Niraj Sharma and Dr. Mike Lloyd examine new evidence challenging several long-standing assumptions in cardiac electrophysiology: when to choose catheter ablation over antiarrhythmic drug therapy for atrial fibrillation, whether left bundle branch area pacing should replace conventional right ventricular pacing in patients who require substantial ventricular pacing, and how broadly the lessons of CAST should continue to restrict flecainide and other Class Ic antiarrhythmic drugs.The atrial fibrillation discussion brings togethe... -
EP Edge® Journal Watch Issue 34 August 2026: ICD Shocks, Troponin, PFA Safety, LOSE-AF Weight Loss and POTS, Radiation Expose in the EP Lab 24.08.2026 27mWhat can nine carefully selected studies teach us about the changing practice of cardiac electrophysiology?In EP Edge® Journal Watch Issue 34, August 2026, Dr. Sharma provides a clinically focused review of emerging evidence across atrial fibrillation, pulsed field ablation, implantable cardiac devices, sudden death prevention, resuscitation, occupational radiation safety, and postural orthostatic tachycardia syndrome.This episode examines whether transvenous and subcutaneous ICD shocks produce different patterns of myocardial injury; the incidence and clinical meaning of migraine following pu... -
EP Edge® Journal Watch Issue 33, August 2026: Anticoagulation After AF Ablation, PFA Safety, Lead Extraction and Sudden Death Risk 17.08.2026 27mHow long should anticoagulation continue after an apparently successful atrial fibrillation ablation? Should prophylactic pulmonary vein isolation be added during typical atrial flutter ablation in patients with heart failure? What do emerging data reveal about neurologic events, hemolysis, and renal safety with pulsed-field ablation?In EP Edge® Journal Watch Issue 33, August 2026, Dr. Sharma provides a clinically focused and thought-provoking review of nine important cardiac electrophysiology studies published in Heart Rhythm and JACC: Clinical Electrophysiology.This episode examines: The pro... -
EP Edge® Journal Watch Issue 32 August 2026: AF Ablation Anticoagulation, Flecainide After CAST, AI-ECG & PFA Mapping 10.08.2026 24mCan anticoagulation be safely discontinued after successful atrial fibrillation ablation? Is the traditional prohibition against flecainide in structural heart disease too broad or does CAST remain an essential warning? And can AI-enabled ECGs, unipolar voltage mapping, and cardiac MRI improve how we detect AF and characterize arrhythmic substrate?In EP Edge® Journal Watch Issue 32, Dr. Niraj Sharma examines important electrophysiology research published in Heart Rhythm and JACC: Clinical Electrophysiology, translating the methodology, statistical findings, limitations, and clinical implicatio... -
EP Edge® Journal Watch Issue 31, August 2026: Caffeine, Wine, Atrial Fibrillation, Pulsed-Field Ablation and Sudden Cardiac Death 03.08.2026 26mIn EP Edge® Journal Watch Issue 31, August 2026, Dr. Sharma examine new evidence that challenges several familiar assumptions in cardiac electrophysiology.Should patients with atrial fibrillation routinely stop drinking coffee? An American Heart Association scientific statement reviews the cardiovascular effects of caffeine, including randomized evidence showing a 39% lower risk of recurrent AF among habitual coffee drinkers who continued coffee after cardioversion. The discussion separates ordinary coffee consumption from energy drinks and concentrated caffeine while considering premature ven... -
EP Edge® Journal Watch Issue 30: VISION AF, Pulsed Field Ablation Safety, PACE-HF and Conduction System Pacing | July 2026 27.07.2026 23mIn EP Edge® Journal Watch Issue 30, July 2026, we explore the next phase of cardiac electrophysiology, from pulsed field ablation durability and physiologic pacing to neuromodulation, sleep, fitness, and lifetime arrhythmia risk.We begin with the first-in-human VISION AF study, which evaluates an endoscope-enabled pulsed field ablation balloon that allows direct visualization of the electrode-tissue interface. Chronic invasive remapping provides a close look at pulmonary vein isolation durability and raises an important question: could seeing tissue contact become the next major advance in PFA... -
EP Edge® Journal Watch Issue 29: Atrial Fibrillation Ablation vs Antiarrhythmic Drugs, CABANA Progression and Anticoagulation | July 2026 20.07.2026 23mIn EP Edge® Journal Watch Issue 29, July 2026, we examine the evidence reshaping contemporary atrial fibrillation management and the rapidly changing role of catheter ablation.Two major meta-analyses compare catheter ablation with antiarrhythmic drug therapy, addressing rhythm efficacy, serious adverse events, hospitalization, treatment intolerance, and whether medications still deserve an automatic safety advantage. We also review real-world outcomes in older adults after prior antiarrhythmic drug exposure and ask whether another medication or catheter ablation is the more appropriate next st... -
EP Edge × HRS Podcast: CT-Guided VT Ablation & LAA Closure Without AF: InEurHeart and OPINION, Caveolae, Alcohol and AFib, Pulse check and Afib Diagnosis 13.07.2026 29mIn this July 2026 episode of EP Edge Journal Watch, produced in collaboration with the Heart Rhythm Society (HRS), Mike Lloyd and Dr. Niraj Sharma review five studies with direct implications for contemporary cardiac electrophysiology practice.The anchor trials are InEurHeart, a randomized comparison of computed tomography-guided versus conventional catheter ablation for post–myocardial infarction ventricular tachycardia, and OPINION, which evaluates prophylactic surgical left atrial appendage occlusion during valvular heart surgery in patients without known pre-existing atrial fibrillation. U... -
EP Edge® Journal Watch Issue 28, July 2026: Pulsed Field Ablation Goes Mainstream, LAAO vs DOACs, Non-PV Triggers, and LBBAP Lead Position 06.07.2026 33mIn EP Edge® Journal Watch Issue 28, July 2026, Dr. Sharma reviews a major month in cardiac electrophysiology, where new technology is being tested against real-world evidence. This episode covers the rapid commercial adoption of pulsed field ablation, the NCDR AFib Ablation Registry, the VOLT-AF IDE balloon-in-basket PFA study, PFA-related intravascular hemolysis, and the evolving role of non-pulmonary vein triggers in first-time AF ablation.The issue also explores low-cost atrial fibrillation screening with pulse self-exam, next-generation left atrial appendage occlusion with the VERITAS Amul...